Leucoglycemic index predicts post-operative vasopressor-inotropic requirement after adult cardiac surgery

Rohan Magoon1, Armaanjeet Singh1, Ramesh Kashav1

  • 1Department of Cardiac Anaesthesia, Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) and Dr. Ram Manohar Lohia Hospital, New Delhi, India.

Insights

Intensive care unit (ICU) admission leucoglycemic index (LGI) can predict the need for vasopressor-inotropic support after cardiac surgery. An LGI above 1484.75 indicates a higher likelihood of requiring significant post-operative support.

Area of Science:

  • Cardiology
  • Intensive Care Medicine
  • Biomarkers

Background:

  • Cardiac surgery frequently requires substantial post-operative vasoactive-inotropic support.
  • The leucoglycemic index (LGI), calculated from serum glucose and total leucocyte count, has shown prognostic potential.

Purpose of the Study:

  • To determine if ICU-admission LGI can predict the need for post-operative vasopressor-inotropic support in patients undergoing cardiac surgery on cardiopulmonary bypass (CPB).

Main Methods:

  • Retrospective review of 2138 cardiac surgery patients (January 2015 - December 2020).
  • Vasopressor-inotropic requirement assessed using vasoactive-inotropic score (VIS) and indexed VIS (VISi) over 72 hours post-operation.
  • Patients categorized into high (h-VISi ≥3) and low (l-VISi <3) support groups.

Main Results:

  • Multivariate analysis identified LGI (OR: 1.09), prior congestive heart failure, CPB duration, aortic cross-clamp time, and EuroSCORE II as independent predictors of high vasopressor-inotropic support.
  • An LGI cutoff of 1484.75 predicted high VISi (≥3).
  • Elevated LGI correlated with increased vasoplegia, low-cardiac output syndrome, new-onset atrial fibrillation, acute kidney injury, mortality, mechanical ventilation duration, and ICU stay.

Conclusions:

  • An elevated leucoglycemic index (LGI) ≥1484.75 independently predicts the need for significant vasopressor-inotropic support (VISindex ≥3) following adult cardiac surgery on CPB.
  • LGI serves as a valuable predictive biomarker for post-cardiac surgery outcomes.
Abstract

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
574
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
257
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
168